Found 73 matching trials
A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS) PHASE1 This is a Phase 1b, open-label, multicenter study designed to evaluate the ...
Show More Location
University of Arizona Cancer Center - North Campus /ID# 157503
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS PHASE1 This is a two Part study in patients with relapsed/refractory acute myeloid...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies PHASE1 This is a Phase 1 dose-escalation study of PRT1419, a myeloid cell leukemia...
Show More Location
Mid Florida Hematology and Oncology Center
Learn More & Join Trial
Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes PHASE2 Evaluate the safety and efficacy of oral azacitidne (CC-486) twice daily (B...
Show More Location
Local Institution - 113
Learn More & Join Trial
Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome PHASE1 This is a multicenter, open-label, Phase 1 study to assess the safety and a...
Show More Learn More & Join Trial
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML PHASE1 To assess safety and tolerability at increasing dose levels of IO-202 in su...
Show More Location
University California, Davis (117)
Learn More & Join Trial
APR-548 in Combination With Azacitidine for the Treatment of TP53 Myelodysplastic Syndromes (MDS) PHASE1 Phase 1 study evaluating the safety and efficacy of APR-548 in combination ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma PHASE1 The purpose of this clinical trial is to learn how the experimental medicin...
Show More Location
Keck Hospital of USC
Learn More & Join Trial
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia PHASE1 This is an open-label, multicenter, Phase 1b/2 study to determine the safet...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center /ID# 269273
Learn More & Join Trial